Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy.

Byng-Maddick, Rachel; Turner, Carolin T; Pollara, Gabriele; Ellis, Matthew; Guppy, Naomi J; Bell, Lucy C K; Ehrenstein, Michael R; Noursadeghi, Mahdad

Byng-Maddick, Rachel; Turner, Carolin T; Pollara, Gabriele; Ellis, Matthew; Guppy, Naomi J; Bell, Lucy C K; Ehrenstein, Michael R; Noursadeghi, Mahdad.

Afiliação

Byng-Maddick R; Division of Infection and Immunity, University College London, London, United Kingdom.
Turner CT; Division of Medicine, University College London, London, United Kingdom.
Pollara G; Division of Infection and Immunity, University College London, London, United Kingdom.
Ellis M; Division of Infection and Immunity, University College London, London, United Kingdom.
Guppy NJ; Division of Neuropathology, Institute of Neurology, University College London, London, United Kingdom.
Bell LCK; UCL Advanced Diagnostics, London, United Kingdom.
Ehrenstein MR; Division of Infection and Immunity, University College London, London, United Kingdom.
Noursadeghi M; Division of Medicine, University College London, London, United Kingdom.

Front Immunol ; 8: 932, 2017.

Article em En | MEDLINE | ID: mdl-28824652

Palavras-chave

anti-tumor necrosis factor; rheumatoid arthritis; transcriptional profiling; tuberculin skin test; tumor necrosis factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido